High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

BACKGROUND: High expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate, with prolonged survival in several malignant diseases and with the benefit of platinum-based chemotherapy in ovarian cancer. The aim of this study was to evaluate RBM3 in metastatic colorectal cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Siesing, Christina, Sorbye, Halfdan, Dragomir, Anca, Pfeiffer, Per, Qvortrup, Camilla, Pontén, Fredrik, Jirström, Karin, Glimelius, Bengt, Eberhard, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553773/
https://www.ncbi.nlm.nih.gov/pubmed/28800641
http://dx.doi.org/10.1371/journal.pone.0182512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553773/
https://www.ncbi.nlm.nih.gov/pubmed/28800641
http://dx.doi.org/10.1371/journal.pone.0182512

Ejemplares similares